NEWSROOM
20487_FP_Header_Newsroom_Website_2400x900px

The latest from Dr. Falk Pharma

Welcome to our Newsroom, providing you with the latest news, press releases, clinical trial announcements, events, and more from Dr. Falk Pharma.

Follow us on LinkedIn!

Corporate

Following the footsteps of our founder - The End

Elena looks back and summarizes her journey: it's a collection of emotional encounters, funny moments, and, most of all, it's a big THANK YOU!

Event

Back to the Future – Unleashing the Power of Established Drugs

Lunch satellite symposium on 21.02.2025 during the Congress of ECCO in Berlin

Press release

Dr. Falk Pharma acquires Kynos Therapeutics

...adding acute pancreatitis as a therapeutic focus and further strengthening its development portfolio

Corporate

Elena in the UK

... following her grandpa's footsteps in Edinburgh and London

Corporate

Following the footsteps of our founder

Herbert Falk's granddaughter Elena decided to follow her grandpa's footsteps. Why? Find out more and follow Elena on her journey.

Press release

Dosing of the First United States Patient

...and expansion of the Phase 2b Study of Naronapride in Gastroparesis

Corporate

In memory of our founder

100 years ago today, Dr. Dr. Herbert Falk was born

Press release

New Addition to the Management Board

The new Technical Operations business unit will be headed up by Dr. Andreas Rascher

Press release

FDA clearance of IND application for naronapride

...to treat gastroparesis and subsequent expansion of ongoing phase 2b study to the US

Press release

Advancing the development of naronapride...

...for patients with PPI-non-responsive symptomatic GERD as the second naronapride indication